Search QatarPRNetwork.com

Home >> Healthcare and Fitness

Cutting-Edge Deep Learning Solutions That Work With Radiologists to Improve Breast Cancer Detection to Be Launched in Qatar

Friday, January 21, 2022/ Editor -  

Share

Home >> Healthcare and Fitness
 Kheiron Medical Technologies partners with Medtech Corporation to bring AI breast screening solution Mia® to Qatar healthcare community
Mia is the first and only AI-enabled independent reader for breast cancer screening to be commercially available in Qatar
 
 
Doha - Qatar - 25, July 2021:   Mia®, a deep learning artificial intelligence (AI) solution that works with radiologists to improve breast cancer detection, avoid unnecessary biopsies and ultimately improve the patient experience for all women is being launched in Qatar. 
 
UK-based Kheiron Medical Technologies has signed an agreement with Medtech Corporation, one of Qatar’s leading suppliers of medical and laboratory equipment, to bring its Mia solution to the Qatar market. With patented AI technology developed on more than three million breast images, Mia (Mammography Intelligent Assessment) is designed to support breast radiologists in making the critical decision to recall women for further testing based on their mammography screening. 
 
Mia is the first solution of its kind to receive the CE (European regulatory clearance) mark for use as an AI-enabled independent reader for the detection of breast cancer. Through rigorous clinical studies and testing, Mia has learnt to read mammograms to the same level of detail as a consulting radiologist. 
In double-reading mammography workflows where scans are reviewed by two radiologists, Mia can be deployed independently alongside a single human reader. This delivers the quality improvements needed to ensure the sustainability of breast screening services and frees up clinicians to spend more time with patients. Mia can also be deployed as a concurrent reader or in double reader triage.
 
Her Majesty’s Trade Commissioner for the Middle East, Simon Penney, added: “I am delighted that Kheiron Medical Technologies is bringing their breakthrough AI platform for breast screening, Mia, to the Gulf region, and that the UK’s Department for International Trade played a role in making this happen.  Kheiron’s technology brings pioneering artificial intelligence to the frontline, freeing up clinicians’ time and helping to save lives.”
 
Speaking at a signing ceremony between Kheiron and Medtech Corporation, Alex Hamlow, Kheiron’s Chief Commercial Officer, said; “Our mission at Kheiron is to support breast screening professionals in the fight against breast cancer with proven and effective AI-enabled tools. We’re excited that Mia is the first AI independent reader solution available for use within the breast screening community in Qatar. Based on its performance in the UK and Europe, Mia represents a major breakthrough in helping radiologists to dramatically improve breast cancer detection and patient outcomes. 
 
“According to the WHO’s International Agency for Research on Cancer, breast cancer was the most prevalent of all cancers detected in Qatar in 2020, accounting for 37.5% of all new cancer cases detected in women. I’m excited that Mia can help both radiologists and the women they care for,” Mr Hamlow continued.
 
“We are looking forward to bringing Kheiron’s Mia solution to Qatar’s breast screening community,” comments Dr. Hassan Kunhi, Chief Executive Officer for Medtech.  “Like Kheiron, we are driven by a desire to achieve the highest quality in everything we do. Mia has tremendous potential to improve radiologist productivity and empower breast screening professionals to detect potential malignancies more accurately and quickly. This means that Mia ultimately will help save more lives in the fight against breast cancer.”
 
Mia’s effectiveness has been proven in one of the most ambitious clinical studies in radiology AI to date and tested across multiple demographics and mammography devices.  It was one of the recipients of the UK Government’s first AI in Health and Care Awards through which Mia is undergoing multiple deployments and clinical studies across 15 sites in the UK as a benchmark for how to integrate new, cutting edge technologies into the NHS safely and effectively. Kheiron and AI Advance are currently working with an Australian breast-screening provider to establish the protocols for a forthcoming clinical trial, details of which will soon be announced.
 
Mia will be available to the UAE, Qatar and Oman markets pending local requirements.

Previous in Healthcare and Fitness

Next in Healthcare and Fitness


Home >> Healthcare and Fitness Section

Latest Press Release

Keeta Sets Stage for Qatar Market Entry with Exclusive Founding Vendor Program f ...

Passenger Growth Hits 5% in May

Nasser Bin Khaled Automobiles Hosts Private Screening of 'F1: The Movie' In coll ...

May Air Cargo Demand Up 2.2% Despite Trade Disruptions

Qatar Insurance Group Earns MSCI's Highest ESG Rating, Cementing Its Leadership ...

Zulal wellness resort partners with qatar airways privilege club to offer exclu ...

Education Above All Foundation Announces New Collaboration with the American Cha ...

Auto Class Cars Launches its Special Summer offer on Maxus D60 and D90 max SUVs

Qatar Automobiles Company – FUSO: Driving Progress Across Industries in Qatar

Dukhan Bank Ranks #62 on Forbes Middle East's Top 100 Listed Companies for 2025

Nissan hosts world premiere of all-new Patrol NISMO in the Middle East, elevatin ...

The Mitsubishi Montero Sport.. Attractive design, High Performance and Durable

Hibrid and Alibaba Cloud Sign MoU to Deliver Advanced Streaming and Comprehensiv ...

CASIO Middle East Africa Marks Six Decades of Calculator Legacy

Dukhan Bank Named “Qatar's Best Bank for Consumers” at Euromoney Awards for Exce ...

Get Ready for Fabulous Summer Looks with BADgal BANG! Power Blue Mascara!

QIC Blog Launches Summer Themed Travel Advisory Series

Doha Mall Expands Dining Options with New Restaurants and the Launch of The Food ...

WCM-Q research highlights Qatar's path to 'global health excellence' in cancer c ...

Msheireb Museums and Sidra Medicine Host Science Café on AI in Precision Medici ...